

255. CSIM- Top Papers of the Year 2024 Live Episode
Oct 23, 2024
Rajender Hanmiah, an academic internist with 27 years of experience, shares insights from the Canadian Conference of Internal Medicine. He discusses innovative blood biomarkers for Alzheimer's diagnosis and critical findings on atrial fibrillation risks. The conversation dives into promising new treatments for NASH, alongside challenges in drug trials, including significant side effects. Key highlights also cover the intersection of liver disease, long COVID, and the importance of continued vaccination efforts in tackling public health issues.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 3min
Innovations in Alzheimer's Diagnosis and Atrial Fibrillation Insights
02:40 • 17min
Advancements in NASH Treatment
19:10 • 4min
Analyzing Drug Side Effects and Study Limitations
23:26 • 2min
Exploring Liver Disease and Long COVID
25:31 • 9min
Steroid Therapy in Pneumonia Treatment
34:58 • 18min
Passion for Podcasting and Engaging with Evidence-Based Medicine
53:27 • 2min